Regionshospitalet Silkeborg

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Crohn's disease1 trial
• Fibromyalgia1 trial
• Irritable bowel syndrome1 trial
• Long COVID and ME/CFS1 trial
• Rheumatoid arthritis1 trial
• Type 1 diabetes1 trial
• Ulcerative colitis1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Karolinska Institutet1 trial
• Regionshospitalet Silkeborg1 trial
• Takeda1 trial
• University of Aarhus1 trial

Running trials

• Recruiting

  A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.

  NCT01491815· Phase 4· Karolinska Institutet· Source

• Recruiting

  The MICRON Study - A Steno 1 Substudy

  NCT07270172· University of Aarhus· Source

  Contact: Sofie H Wilken, MD, PhD student

• Active, not recruiting

  DISTRESS Trial Functional Disorders - the DISTRESS Trial

  NCT06025617· Regionshospitalet Silkeborg· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Rheumatoid arthritis1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source